Innovis Asset Management LLC Apellis Pharmaceuticals, Inc. Transaction History
Innovis Asset Management LLC
- $260 Billion
- Q3 2023
A detailed history of Innovis Asset Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Innovis Asset Management LLC holds 12,535 shares of APLS stock, worth $341,704. This represents 0.18% of its overall portfolio holdings.
Number of Shares
12,535Holding current value
$341,704% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
114MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$447 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$316 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$303 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$267 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$158 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.99B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...